2021Unpublished venueOpen access

Bactericidal Effects of Phytochemicals on Mycobacterium leprae , the Causative Agent of Leprosy

Chukwuebuka Egbuna, Muhammad Akram, Surajudeen Abiola Abdulrahman, Andrew G. Mtewa, Mithun Rudrapal, Kingsley C. Patrick‐Iwuanyanwu, Saher Rahat, Iram Ghaffar, Amna Siddique, Jonathan C. Ifemeje, Michael Chinedu Olisah, Mihnea‐Alexandru Găman, Bùi Thanh Tùng, Chandan Shivamallu, Chukwuemelie Zedech Uche, Johra Khan

Open full text 1 citations

Abstract

Leprosy, also called as Hansen's disease, is an infectious disease caused by Mycobacterium leprae . This bacterial infection mostly affects the mucous membranes and the peripheral nerves of the body. Leprosy can also lead to skin discoloration. The main mode of transmission of M. leprae is prolonged social contact with an untreated or affected person. The majority of cases are reported in about 105 countries mostly located in the Americas, Africa, Southeast Asia, Western Mediterranean, and Eastern Pacific. In 2018, India, Brazil, and Indonesia accounted for about 80% of the cases reported worldwide. Multidrug therapy was introduced in the early 1980s and this remarkably reduced the prevalence of leprosy. The point of entry of M. leprae is the upper airway of a susceptible host. The diagnosis of leprosy is mainly clinical – based on a variety of clinical features arising from two types of reactions caused by the presence of the infective agent in the body. In this chapter, the epidemiology, clinical features, and management of leprosy, including the potentials of medicinal plants for the treatment of leprosy, are discussed. In addition, the usefulness of computational tools in designing drugs against various biological targets of M. leprae is discussed.

Open-access reader

About this research paper

What this paper is about

Leprosy, also called as Hansen's disease, is an infectious disease caused by Mycobacterium leprae . This bacterial infection mostly affects the mucous membranes and the peripheral nerves of the body. Leprosy can also lead to skin discoloration. The main mode of transmission of M. leprae is prolonged social contact with an untreated or affected person. The majority of cases are reported in about 105 countries mostly located in the Americas, Africa, Southeast Asia, Western Mediterranean, and Eastern Pacific. In 2018, India, Brazil, and Indonesia accounted for about 80% of the cases reported worldwide. Multidrug therapy was introduced in the early 1980s and this remarkably reduced the prevalence of leprosy. The point of entry of M. leprae is the upper airway of a susceptible host. The diagnosis of leprosy is mainly clinical – based on a variety of clinical features arising from two types of reactions caused by the presence of the infective agent in the body. In this chapter, the epidemiology, clinical features, and management of leprosy, including the potentials of medicinal plants for the treatment of leprosy, are discussed. In addition, the usefulness of computational tools in designing drugs against various biological targets of M. leprae is discussed.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Leprosy, also called as Hansen's disease, is an infectious disease caused by Mycobacterium leprae . This bacterial infection mostly affects the mucous membranes and the peripheral nerves of the body. Leprosy can also lead to skin discoloration. The main mode of transmission of M. leprae is prolonged social contact with an untreated or affected person. The majority of cases are reported in about 105 countries mostly located in the Americas, Africa, Southeast Asia, Western Mediterranean, and Eastern Pacific. In 2018, India, Brazil, and Indonesia accounted for about 80% of the cases reported worldwide. Multidrug therapy was introduced in the early 1980s and this remarkably reduced the prevalence of leprosy. The point of entry of M. leprae is the upper airway of a susceptible host. The diagnosis of leprosy is mainly clinical – based on a variety of clinical features arising from two types of reactions caused by the presence of the infective agent in the body. In this chapter, the epidemiology, clinical features, and management of leprosy, including the potentials of medicinal plants for the treatment of leprosy, are discussed. In addition, the usefulness of computational tools in designing drugs against various biological targets of M. leprae is discussed.

Key concepts: Leprosy, Mycobacterium leprae, Disease, Transmission (telecommunications), Medicine, Immunology, Biology, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Bactericidal Effects of Phytochemicals on Mycobacterium leprae , the Causative Agent of Leprosy — Research Paper | ScholarLens